Press releases

  19/12/2019 18:00
|

Quantum Genomics Initiates its Pivotal Phase III FRESH Trial in Difficult-to-Treat and Resistant Hypertension

  16/12/2019 18:00
|

Quantum Genomics to Participate in Biotech Showcase 2020

  09/12/2019 18:00
|

Quantum Genomics and Biolab Sanus Pharmaceutical Enter into Exclusive Licensing and Collaboration Agreement for Firibastat in Latin America

  07/10/2019 07:30
|

Quantum Genomics enters into exclusive negotiations for its first partnership

  03/10/2019 18:00
|

Quantum Genomics Reports First Half 2019 Financial Results and Provides Corporate Update

  11/09/2019 19:35
|

Quantum Genomics Launches Study of Firibastat in Patients with Renal Failure

  02/09/2019 18:00
|

Quantum Genomics Announces Positive FDA Feedback on Phase III Program Design of Firibastat in Resistant Arterial Hypertension

  03/07/2019 18:00
|

Quantum Genomics Selected to Enter the European Rising Tech Label

  27/06/2019 18:00
|

Quantum Genomics Announces Result of Annual General Meeting

  12/06/2019 18:00
|

A key milestone reached by Quantum Genomics in the development of firibastat

  06/06/2019 18:00
|

Quantum Genomics Enrolls First Patient in QUORUM Phase IIb Study of Firibastat in Heart Failure Patients

  10/05/2019 12:00
|

Quantum Genomics Announces the Publication of a New Scientific Article in the Journal Hypertension

  26/04/2019 14:00
|

Quantum Genomics Announces the Publication of its Phase IIb NEW-HOPE Study Results of Firibastat in Arterial Hypertension in the Journal Circulation

  17/04/2019 18:00
|

Quantum Genomics Receives First Regulatory and Ethics Approvals to Initiate Phase IIb QUORUM Study of Firibastat in Heart Failure

  28/03/2019 18:00
|

Quantum Genomics Reports Full-Year 2018 Financial Results

  20/03/2019 18:00
|

Quantum Genomics Announces Positive Results from New Preclinical Studies on Firibastat

  25/02/2019 18:00
|

Quantum Genomics Completes Enrollment in Its Pharmacokinetic Clinical Study of Firibastat

  06/02/2019 18:00
|

Quantum Genomics Announces the Publication of Two Scientific Articles Confirming the Efficacy of Firibastat for Heart Failure

  31/01/2019 18:45
|

Quantum Genomics Presents its 2019 Corporate Action Plan

  23/01/2019 18:00
|

The Association of Black Cardiologists and the Heart Institute of the Caribbean Conclude Successful First Annual Joint "Masters of Cardiology" Conference in Kingston, Jamaica

  17/01/2019 18:00
|

Quantum Genomics Appoints Steering Committee for its Phase III Pivotal Trial in Resistant Hypertension